These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 23922299)

  • 1. Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
    Afanasiev OK; Yelistratova L; Miller N; Nagase K; Paulson K; Iyer JG; Ibrani D; Koelle DM; Nghiem P
    Clin Cancer Res; 2013 Oct; 19(19):5351-60. PubMed ID: 23922299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
    Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
    Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.
    Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
    Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
    Miller NJ; Church CD; Fling SP; Kulikauskas R; Ramchurren N; Shinohara MM; Kluger HM; Bhatia S; Lundgren L; Cheever MA; Topalian SL; Nghiem P
    J Immunother Cancer; 2018 Nov; 6(1):131. PubMed ID: 30482247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.
    Walsh NM; Fleming KE; Hanly JG; Dakin Hache K; Doucette S; Ferrara G; Cerroni L
    Hum Pathol; 2016 Jun; 52():190-6. PubMed ID: 26980039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma.
    Feldmeyer L; Hudgens CW; Ray-Lyons G; Nagarajan P; Aung PP; Curry JL; Torres-Cabala CA; Mino B; Rodriguez-Canales J; Reuben A; Chen PL; Ko JS; Billings SD; Bassett RL; Wistuba II; Cooper ZA; Prieto VG; Wargo JA; Tetzlaff MT
    Clin Cancer Res; 2016 Nov; 22(22):5553-5563. PubMed ID: 27166398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.
    Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival.
    Lipson EJ; Vincent JG; Loyo M; Kagohara LT; Luber BS; Wang H; Xu H; Nayar SK; Wang TS; Sidransky D; Anders RA; Topalian SL; Taube JM
    Cancer Immunol Res; 2013 Jul; 1(1):54-63. PubMed ID: 24416729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global PD-L1 Signals and Tumor-Infiltrating Lymphocytes: Markers of Immunogenicity in Different Subsets of Merkel Cell Carcinoma and Potential Therapeutic Implications.
    Walsh NM; Castonguay MC; Carter MD; Pasternak S; Ly TY; Doucette S; Hanly JG; Saggini A; Cerroni L
    Am J Dermatopathol; 2019 Nov; 41(11):819-825. PubMed ID: 31634167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
    Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
    Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8
    Jing L; Ott M; Church CD; Kulikauskas RM; Ibrani D; Iyer JG; Afanasiev OK; Colunga A; Cook MM; Xie H; Greninger AL; Paulson KG; Chapuis AG; Bhatia S; Nghiem P; Koelle DM
    Cancer Immunol Res; 2020 May; 8(5):648-659. PubMed ID: 32179557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into anti-tumor immunity
    Jani S; Church CD; Nghiem P
    Front Immunol; 2023; 14():1172913. PubMed ID: 37287968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merkel cell polyomavirus-specific and CD39
    Ryu H; Bi TM; Pulliam TH; Sarkar K; Church CD; Kumar N; Mayer-Blackwell K; Jani S; Ramchurren N; Hansen UK; Hadrup SR; Fling SP; Koelle DM; Nghiem P; Newell EW
    Cell Rep Med; 2024 Feb; 5(2):101390. PubMed ID: 38340724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.
    Chapuis AG; Afanasiev OK; Iyer JG; Paulson KG; Parvathaneni U; Hwang JH; Lai I; Roberts IM; Sloan HL; Bhatia S; Shibuya KC; Gooley T; Desmarais C; Koelle DM; Yee C; Nghiem P
    Cancer Immunol Res; 2014 Jan; 2(1):27-36. PubMed ID: 24432305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
    Colunga A; Pulliam T; Nghiem P
    Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses.
    Pulliam T; Jani S; Goff PH; Bhakuni R; Tabachnick-Cherny S; Smythe K; Seaton BW; Tachiki L; Kulikauskas R; Church C; Koelle DM; Nghiem P; Bhatia S
    J Immunother Cancer; 2024 Oct; 12(10):. PubMed ID: 39401968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus.
    Rodig SJ; Cheng J; Wardzala J; DoRosario A; Scanlon JJ; Laga AC; Martinez-Fernandez A; Barletta JA; Bellizzi AM; Sadasivam S; Holloway DT; Cooper DJ; Kupper TS; Wang LC; DeCaprio JA
    J Clin Invest; 2012 Dec; 122(12):4645-53. PubMed ID: 23114601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
    Ricci C; Righi A; Ambrosi F; Gibertoni D; Maletta F; Uccella S; Sessa F; Asioli S; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
    Endocr Pathol; 2020 Mar; 31(1):21-32. PubMed ID: 31808008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CD4
    Longino NV; Yang J; Iyer JG; Ibrani D; Chow IT; Laing KJ; Campbell VL; Paulson KG; Kulikauskas RM; Church CD; James EA; Nghiem P; Kwok WW; Koelle DM
    Cancer Immunol Res; 2019 Oct; 7(10):1727-1739. PubMed ID: 31405946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
    Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
    Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.